Literature DB >> 7204994

Determination of alternative pathway of complement activity in mouse serum using rabbit erythrocytes.

H Van Dijk, P M Rademaker, J M Willers.   

Abstract

Rabbit, mouse and sheep erythrocytes expressing different concentrations of membrane sialic acid were used to study possible modes of activation of the alternative complement (C) pathway in mouse, human and guinea pig serum. Mouse erythrocytes activated only human serum, whereas rabbit erythrocytes activated the sera of all three species. Based on the observation that rabbit erythrocytes activate the murine alternative C pathway a method for estimation of alternative C pathway activity (AP50 value) in mouse serum was devised analogous to that used for human AP50 determination. The method is not very sensitive to ageing or to batch variation of the indicator cells. The AP50 value of mouse serum measured by this method is of the same order as for human and guinea pig serum. Mouse serum AP50 activity is partly determined by natural anti-rabbit erythrocyte antibodies and is sensitive to heating (15' at 48 degrees C and 4' at 56 degrees C), and to the actions of cobra venom factor, zymosan and cysteine. Strain and sex differences with respect to AP50 activities of mouse sera were observed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7204994     DOI: 10.1016/0022-1759(80)90091-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  A novel method for direct measurement of complement convertases activity in human serum.

Authors:  A M Blom; E B Volokhina; V Fransson; P Strömberg; L Berghard; M Viktorelius; T E Mollnes; M López-Trascasa; L P van den Heuvel; T H Goodship; K J Marchbank; M Okroj
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

2.  Analysis of synthetic sites of fourth and fifth components of serum complement system in allogeneic bone marrow chimaeras.

Authors:  L Geng; K Iwabuchi; S Sakai; M Ogasawara; M Fujita; K Ogasawara; M Kakinuma; R A Good; K Morikawa; K Onoé
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

3.  Arthropathic group A streptococcal cell walls require specific antibody for activation of human complement by both the classical and alternative pathways.

Authors:  R A Eisenberg; J H Schwab
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

4.  Studies on anti-infective mechanism of the traditional Chinese medicinal preparation "anti-inflammatory agent no. 6"--its influence on immune functions of mice.

Authors:  Z H Xue; X H Zhang; Y B Liu; C X Cai; C Y Zhang
Journal:  J Tongji Med Univ       Date:  1987

5.  Opsonins in normal mouse serum for the phagocytic killing of Proteus mirabilis by murine neutrophils.

Authors:  J J Finlay-Jones; N L Hill; M F Nulsen; H Pruul; P J McDonald
Journal:  Br J Exp Pathol       Date:  1984-12

6.  Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.

Authors:  H Van Dijk; J Van Voorst; I G Jankowski; J W Imhof; J A Kerckhaert
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

7.  Interactions of killed Listeria monocytogenes with the mouse complement system.

Authors:  K P van Kessel; A C Antonissen; H van Dijk; P M Rademaker; J M Willers
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

8.  Antitumour activity of endotoxin, concanavalin A and poly I: C and their ability to elicit tumour necrosis factor, cytostatic factors, and interferon in vivo.

Authors:  N Bloksma; C F Kuper; F M Hofhuis; B Benaissa-Trouw; J M Willers
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.